Gibson Dunn Advises XOMA Royalty Corporation in Connection with Acquisition of ESSA Pharma by XenoTherapeutics
Dan Mulloy
Gibson Dunn represented XOMA Royalty Corporation in connection with the acquisition of ESSA Pharma Inc. (Nasdaq: EPIX) by XenoTherapeutics, Inc., … The post Gibson Dunn Advises XOMA Royalty Corporation in Connection with Acquisition of ESSA Pharma by XenoTherapeutics appeared first on Gibson Dunn .